| November 30 - December 1, 2023 |
Advancing the Development of Pediatric Therapeutics on Drug Dosing in Pediatric Patients |
| October 30, 2023 |
Defining “Candy-Like” Nonprescription Drug Products |
| October 17, 2023 |
Prediction of Oral Drug Absorption & Biopharmaceutic Risk Using a Dissolution-Hollow Fiber Membrane |
| August 29 - 31, 2023 |
Physiologically Based Biopharmaceutics Modeling (PBBM) Best Practices for Drug Product Quality |
| May 23-24, 2023 |
Drug Dissolution in Oral Drug Absorption Workshop |
| May 11, 2023 |
Creating a Roadmap to Quantitative Systems Pharmacology-Informed Rare Disease Drug Development Workshop |
| February 17, 2023 |
Application of Artificial Intelligence & Machine Learning for Precision Medicine |
| November 9, 2022 |
Bridging Drug Efficacy and Safety to the Obese: Considerations and Scientific Approaches |
| July 13-14, 2022 |
Co-Processed API Workshop |
| May 16, 2022 |
Pharmacokinetic Evaluation in Pregnancy |
| April 13, 2022 |
Biosimilars: A Decade of Experience and Future Directions |
| January 26, 2022 |
IMPACT Bootcamp: Navigating the Journey from Digital Health Technologies to Meaningful Patient Outcomes |
|
| December 6, 2021 |
Drug Permeability: Best Practices for BCS-based Biowaivers |
|
| October 21-22, 2021 |
Fetal Pharmacology and Therapeutics |
| October 13-14, 2021 |
Analgesic Clinical Trial Designs, Extrapolation, and Endpoints in Patients from Birth to Under Age 2 |
| September 1-2, 2021 |
Advancing the Development of Pediatric Therapeutics |
| February 10, 2021 |
Collaborating to Advance Health Equity for Diabetes and Chronic Kidney Disease |
| October 22, 2020 |
Pediatric Dose Selection |
| October 8, 2020 |
Assessing Changes in Pharmacokinetics of Drugs in Liver Disease |
| August 14, 2020 |
3D Cell Culture Models for Drug PK, Safety, and Efficacy Assessment |
| July 23-24, 2020 |
Topical Drug Development: Evolution of Science and Regulatory Policy II |
